HRP20150109T1 - Kompozicije za dijetetske proizvode bazirane na proteinima - Google Patents
Kompozicije za dijetetske proizvode bazirane na proteinima Download PDFInfo
- Publication number
- HRP20150109T1 HRP20150109T1 HRP20150109TT HRP20150109T HRP20150109T1 HR P20150109 T1 HRP20150109 T1 HR P20150109T1 HR P20150109T T HRP20150109T T HR P20150109TT HR P20150109 T HRP20150109 T HR P20150109T HR P20150109 T1 HRP20150109 T1 HR P20150109T1
- Authority
- HR
- Croatia
- Prior art keywords
- composition according
- composition
- amino acid
- protein
- combination
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims 23
- 102000004169 proteins and genes Human genes 0.000 title claims 7
- 108090000623 proteins and genes Proteins 0.000 title claims 7
- 235000005911 diet Nutrition 0.000 title claims 2
- 230000000378 dietary effect Effects 0.000 title claims 2
- 150000001413 amino acids Chemical group 0.000 claims 11
- 229940024606 amino acid Drugs 0.000 claims 7
- 235000001014 amino acid Nutrition 0.000 claims 7
- 150000004676 glycans Chemical class 0.000 claims 6
- 229920001282 polysaccharide Polymers 0.000 claims 6
- 239000005017 polysaccharide Substances 0.000 claims 6
- 235000018102 proteins Nutrition 0.000 claims 6
- 238000006116 polymerization reaction Methods 0.000 claims 4
- 102100026189 Beta-galactosidase Human genes 0.000 claims 3
- 229920001202 Inulin Polymers 0.000 claims 3
- 108010059881 Lactase Proteins 0.000 claims 3
- 239000004472 Lysine Substances 0.000 claims 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 3
- 108010030291 alpha-Galactosidase Proteins 0.000 claims 3
- 102000005840 alpha-Galactosidase Human genes 0.000 claims 3
- 108010005774 beta-Galactosidase Proteins 0.000 claims 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical group O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims 3
- 229940029339 inulin Drugs 0.000 claims 3
- 229960000310 isoleucine Drugs 0.000 claims 3
- 229940116108 lactase Drugs 0.000 claims 3
- 229920000642 polymer Polymers 0.000 claims 3
- 108090000790 Enzymes Proteins 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 2
- 239000004473 Threonine Substances 0.000 claims 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 2
- 229940088598 enzyme Drugs 0.000 claims 2
- 239000003797 essential amino acid Substances 0.000 claims 2
- 235000020776 essential amino acid Nutrition 0.000 claims 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 2
- 229930182817 methionine Natural products 0.000 claims 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 2
- 235000004252 protein component Nutrition 0.000 claims 2
- 239000004474 valine Substances 0.000 claims 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Natural products NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims 1
- 229930064664 L-arginine Natural products 0.000 claims 1
- 235000014852 L-arginine Nutrition 0.000 claims 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 1
- 229930182844 L-isoleucine Natural products 0.000 claims 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims 1
- 206010033307 Overweight Diseases 0.000 claims 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
- 229960002173 citrulline Drugs 0.000 claims 1
- 235000013477 citrulline Nutrition 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 206010016766 flatulence Diseases 0.000 claims 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical group OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims 1
- 229940107187 fructooligosaccharide Drugs 0.000 claims 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 claims 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
- 239000000178 monomer Substances 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 229960003104 ornithine Drugs 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- 239000011591 potassium Substances 0.000 claims 1
- 229940068988 potassium aspartate Drugs 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Dispersion Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- General Preparation And Processing Of Foods (AREA)
Claims (13)
1. Kompozicija dijetetskog proizvoda za humanu upotrebu za tretiranje pretilosti i prekomjerne težine, pri čemu spomenuta kompozicija sadrži:
- proteinsku komponentu koja sadrži najmanje jedan protein, i spomenuti protein je formiran od aminokiselinskih jedinica;
- dodatnu aminokiselinsku komponentu koja sadrži aminokiselinu koja je izabrana iz grupe koja sadrži:
- lizin;
- triptofan;
- njihovu kombinaciju,
naznačeno time da spomenuta dodatna komponenta sadrži određenu količinu spomenutih lizina i/ili triptofana tako da se dodavanjem spomenute dodatne komponente spomenutoj proteinskoj komponenti spomenute kompozicije osigurava željena kombinacija esencijalnih aminokiselinskih jedinica, pri čemu u cjelini promatrano spomenuti lizin i triptofan u spomenutoj kompoziciji imaju težinski odnos koji se nalazi između 2,5 i 4, i time da spomenuta kompozicija dalje sadrži komponentu koja je izabrana iz grupe koja sadrži:
- polisaharid, pri čemu spomenuti polisaharid ima polimerni lanac, i spomenuti polimerni lanac se u suštini sastoji od fruktoznih jedinica koje su međusobno povezane s β(2→1) glikozidnim vezama na anomernom C2, pri čemu je spomenuti polisaharid naznačen sa stupnjem polimerizacije, i spomenuti stupanj polimerizacije je broj monomernih jedinica u spomenutom polimernom lancu;
- enzim, koji je izabran iz grupe koja sadrži:
- α-galaktozidazu;
- laktazu;
- smjesu α-galaktozidaze i laktaze;
- enzim koji ima djelovanje smanjivanja nadimanja;
- njihovu kombinaciju;
- njihovu kombinaciju.
2. Kompozicija prema zahtjevu 1, naznačena time da se spomenuti težinski odnos nalazi između 2,7 i 3,2.
3. Kompozicija prema zahtjevu 1, naznačena time da spomenuti polisaharid ima terminalnu glukoznu jedinicu.
4. Kompozicija prema zahtjevu 1, naznačena time da je spomenuti polisaharid inulin, i spomenuti inulin ima stupanj polimerizacije veći od 20.
5. Kompozicija prema zahtjevu 1, naznačena time da je spomenuti polisaharid fruktooligosaharid, koji se također označava sa FOS.
6. Kompozicija prema zahtjevu 5, naznačena time da spomenuti FOS ima stupanj polimerizacije koji se nalazi između 3 i 10.
7. Kompozicija prema zahtjevu 1, koja dalje sadrži izvjesnu količinu sljedeće esencijalne aminokiseline koja je izabrana iz grupe koja sadrži leucin, izoleucin, valin, fenilalanin, treonin, metionin, histidin, njihovu kombinaciju, pri čemu je spomenuta količina prilagođena da u suštini odgovara kombinaciji u kojoj aminokiselinske jedinice imaju odgovarajuće težinske udjele od ukupno 100% aminokiselinskih jedinica izabrane između sljedećih: leucin 19±1%, izoleucin 15±1%, valin 12±1%, fenilalanin 10±1%, treonin 10±1%, metionin 7±1%, histidin 7±1%.
8. Kompozicija prema zahtjevu 1, koja nadalje sadrži aminokiselinu koja je izabrana iz grupe koja sadrži:
- L-ornitin;
- kalij aspartat;
- L-taurin;
- citrulin;
- L-izoleucin;
- glicin;
- L-arginin;
- njihovu kombinaciju.
9. Kompozicija prema zahtjevu 1, koja nadalje sadrži spoj koji oslobađa kalij.
10. Kompozicija prema zahtjevu 1, naznačena time da spomenuta kompozicija sadrži inulin u rasponu od 125 mg do 700 mg po gramu proteina plus aminokiselina.
11. Kompozicija prema zahtjevu 1, naznačena time da spomenuta kompozicija sadrži FOS u rasponu od 125 mg do 700 mg po gramu proteina plus aminokiselina.
12. Kompozicija prema zahtjevu 1, naznačena time da spomenuta kompozicija sadrži α-galaktozidazu u rasponu od 6 do 700 jedinica po gramu proteina plus aminokiselina.
13. Kompozicija prema zahtjevu 1, naznačena time da spomenuta kompozicija sadrži laktazu u rasponu od 3 do 350 jedinica po gramu proteina plus aminokiselina.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08007424A EP2110029A1 (en) | 2008-04-16 | 2008-04-16 | Supplement compositions for protein-based diets |
| EP09753592.6A EP2276358B1 (en) | 2008-04-16 | 2009-04-16 | Compositions for protein-based dietary products |
| PCT/EP2009/002796 WO2009143937A1 (en) | 2008-04-16 | 2009-04-16 | Compositions for protein-based dietary products |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20150109T1 true HRP20150109T1 (hr) | 2015-04-24 |
Family
ID=39800472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20150109TT HRP20150109T1 (hr) | 2008-04-16 | 2015-01-29 | Kompozicije za dijetetske proizvode bazirane na proteinima |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20120064058A1 (hr) |
| EP (2) | EP2110029A1 (hr) |
| ES (1) | ES2530940T3 (hr) |
| HR (1) | HRP20150109T1 (hr) |
| ME (1) | ME02374B (hr) |
| RS (1) | RS53867B1 (hr) |
| SI (1) | SI2276358T1 (hr) |
| WO (1) | WO2009143937A1 (hr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113491334B (zh) * | 2013-02-26 | 2023-11-07 | 味之素株式会社 | 营养组合物 |
| US9301544B2 (en) | 2013-03-14 | 2016-04-05 | R.J. Reynolds Tobacco Company | Protein-enriched tobacco-derived composition |
| US10813383B2 (en) | 2016-12-12 | 2020-10-27 | R.J. Reynolds Tobacco Company | Dehydration of tobacco and tobacco-derived materials |
| US20210267238A1 (en) * | 2018-06-27 | 2021-09-02 | Arla Foods Amba | Instant beverage powder based on blg |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1010449A3 (fr) * | 1996-08-01 | 1998-08-04 | Raffinerie Tirlemontoise Sa | Procede de preparation d'une composition polydipersee de saccharides, composition polydispersee de saccharides, produit alimentaire, pharmaceutique et/ou cosmetique comprenant ladite composition polydispersee. |
| US6866877B2 (en) * | 1998-12-29 | 2005-03-15 | Mac Farms, Inc. | Carbonated fortified milk-based beverage and method for suppressing bacterial growth in the beverage |
| US6455095B2 (en) * | 2000-05-30 | 2002-09-24 | Thermobean L.P. | Thermogenic, appetite suppressing, gas suppressing, complete legume protein formulae; thermobean™ |
| US20020081352A1 (en) * | 2000-12-22 | 2002-06-27 | Rhode Rodger R. | Enzyme food supplement composition comprising lipase and lactase |
| US6706697B1 (en) * | 2002-09-19 | 2004-03-16 | Jason Pharmaceuticals, Inc. | Diabetic nutrition and weight loss drink compositions |
| US7445807B2 (en) * | 2002-10-15 | 2008-11-04 | Western Holdings, Llc | Agglomerated granular protein-rich nutritional supplement |
| GB0320990D0 (en) * | 2003-09-08 | 2003-10-08 | Unilever Plc | Food composition |
| WO2007070454A2 (en) * | 2005-12-09 | 2007-06-21 | Novalife | High protein supplement |
| CN101061819A (zh) * | 2007-02-12 | 2007-10-31 | 石家庄三鹿集团股份有限公司 | 一种调整脂肪酸结构的婴儿配方奶粉 |
-
2008
- 2008-04-16 EP EP08007424A patent/EP2110029A1/en not_active Withdrawn
-
2009
- 2009-04-16 WO PCT/EP2009/002796 patent/WO2009143937A1/en active Application Filing
- 2009-04-16 RS RS20150073A patent/RS53867B1/en unknown
- 2009-04-16 EP EP09753592.6A patent/EP2276358B1/en active Active
- 2009-04-16 ES ES09753592T patent/ES2530940T3/es active Active
- 2009-04-16 SI SI200931120T patent/SI2276358T1/sl unknown
- 2009-04-16 ME MEP-2015-15A patent/ME02374B/me unknown
- 2009-04-16 US US13/263,383 patent/US20120064058A1/en not_active Abandoned
-
2015
- 2015-01-29 HR HRP20150109TT patent/HRP20150109T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2276358B1 (en) | 2014-12-24 |
| ES2530940T3 (es) | 2015-03-09 |
| EP2276358A1 (en) | 2011-01-26 |
| EP2110029A1 (en) | 2009-10-21 |
| RS53867B1 (en) | 2015-08-31 |
| WO2009143937A1 (en) | 2009-12-03 |
| US20120064058A1 (en) | 2012-03-15 |
| ME02374B (me) | 2016-02-20 |
| SI2276358T1 (sl) | 2015-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Anraku et al. | Antioxidant activities of chitosans and its derivatives in in vitro and in vivo studies | |
| Kofuji et al. | Relationship between physicochemical characteristics and functional properties of chitosan | |
| HRP20150109T1 (hr) | Kompozicije za dijetetske proizvode bazirane na proteinima | |
| Holdt et al. | Bioactive compounds in seaweed: functional food applications and legislation | |
| Siew et al. | Role of protein and ferulic acid in the emulsification properties of sugar beet pectin | |
| EP2032170B1 (en) | Anti-inflammatory composition comprising glycine and lactoferrin and the use thereof | |
| TWI409037B (zh) | 增加黏度之營養乳劑 | |
| ES2659413T3 (es) | Composición para fines nutricionales | |
| Majee et al. | Pharmacological, pharmaceutical, cosmetic and diagnostic applications of sulfated polysaccharides from marine algae and bacteria | |
| WO2012084624A9 (en) | Compositions of fat-soluble active ingredients containing plant protein-soy polysaccharide complexes | |
| IN2012DN03632A (hr) | ||
| CA2659783A1 (en) | Thickening composition improved in viscosity development | |
| AU2013343685A1 (en) | Collagen hydrolyzate and use thereof | |
| JP2010540619A5 (hr) | ||
| ES2470390T3 (es) | Composición que contiene polisac�ridos fermentables | |
| Ngwuluka et al. | Functions of bioactive and intelligent natural polymers in the optimization of drug delivery | |
| Agarwal et al. | Preparation and characterization of biodegradable films based on levan polysaccharide blended with gellan gum | |
| JP2008031136A (ja) | ヒアルロン酸産生増強剤 | |
| WO2016011297A2 (en) | Methods and related compositions for improved drug bioavailability and disease treatment | |
| JP4253296B2 (ja) | 健康美容食品 | |
| JP2003048839A (ja) | 免疫反応性ＮＯ合成を誘導するｉＮＯＳ酵素を刺激する組成剤およびその製造方法 | |
| WO2013151081A1 (ja) | 水性液体飲料 | |
| HRP20130925T1 (hr) | Nadomjestak prehrani za stimulaciju muške seksualne funkcije | |
| HRP20160722T1 (hr) | Prehrambena formulacija koja sadrži glikogen | |
| Mathew et al. | Fucoidans: a marine antioxidant |